Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00836342 · ClinicalTrials.gov registry record

Correlation Between Skin Carotenoid Levels and Previous History of Skin Cancer

A clinical trial, sponsored by Massachusetts General Hospital.

Completed
Registry status
81
Enrollment target

NCT00836342: Completed study, sponsored by Massachusetts General Hospital.

NCT00836342 is a clinical trial that has completed, run by Massachusetts General Hospital. The registered enrollment target is 81 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00836342 has completed, sponsored by Massachusetts General Hospital.

COMPLETED
Registry status
81 participants
Enrollment target

Study Summary

The purpose of this study is to determine the difference of skin carotenoid levels between subjects with previous squamous cell carcinomas (SCC), subjects with previous basal cell carcinomas (BCC) and a control group.

Trial Details

FieldValue
Enrollment Target 81 participants
Start Date 2009-02
Est. Completion 2012-01

Sponsor

Massachusetts General Hospital

2,032 total trials

What the Registry Record Tells You About NCT00836342

The ClinicalTrials.gov registry entry for NCT00836342 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 81 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 0 interventions.

NCT00836342 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT00836342 about?

NCT00836342 is a clinical study titled "Correlation Between Skin Carotenoid Levels and Previous History of Skin Cancer". The purpose of this study is to determine the difference of skin carotenoid levels between subjects with previous squamous cell carcinomas (SCC), subjects with previous basal cell carcinomas (BCC) and a control group.

What is the current status of trial NCT00836342?

This trial is currently completed. The enrollment target is 81 participants. The study started on 2009-02. Estimated completion is 2012-01.

Who is sponsoring clinical trial NCT00836342?

This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.